Perrigo Company PLC
PRGO15.065USD
+0.125+0.84%
종가 01/13, 16:00（ET）시세는 15분 지연됩니다
2.07B시가총액
손실P/E TTM
자세한 내용은 Perrigo Company PLC 회사
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Perrigo Company PLC 정보
종목 코드 PRGO
회사 이름Perrigo Company PLC
상장일Dec 17, 1991
CEOLockwood-Taylor (Patrick)
직원 수8379
유형Ordinary Share
회계 연도 종료Dec 17
주소The Sharp Building
도시DUBLIN
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가Ireland
우편 번호D02 TY74
전화3532696738451
웹사이트https://www.perrigo.com/
종목 코드 PRGO
상장일Dec 17, 1991
CEOLockwood-Taylor (Patrick)
Perrigo Company PLC의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+4460.00%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+8650.00%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+3000.00%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+1488.00%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+5150.00%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+5150.00%
Ms. Adriana (Andi) Karaboutis
Ms. Adriana (Andi) Karaboutis
Independent Director
Independent Director
27.63K
+5150.00%
Mr. Orlando D. Ashford
Mr. Orlando D. Ashford
Independent Chairman of the Board
Independent Chairman of the Board
22.17K
+6437.00%
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Independent Director
Independent Director
10.56K
+5150.00%
Ms. Julia M. Brown
Ms. Julia M. Brown
Independent Director
Independent Director
8.03K
+5150.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+4460.00%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+8650.00%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+3000.00%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+1488.00%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+5150.00%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+5150.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Upper respiratory
182.00M
17.44%
Pain and sleep-aids
169.20M
16.22%
Skincare and personal hygiene
150.60M
14.43%
Healthy lifestyle
133.80M
12.82%
Digestive health
116.10M
11.13%
기타
291.60M
27.95%
지역별USD
이름
수익
비율
United States
635.30M
60.89%
Europe
384.00M
36.81%
All other countries
24.00M
2.30%
사업별
지역별
사업별USD
이름
수익
비율
Upper respiratory
182.00M
17.44%
Pain and sleep-aids
169.20M
16.22%
Skincare and personal hygiene
150.60M
14.43%
Healthy lifestyle
133.80M
12.82%
Digestive health
116.10M
11.13%
기타
291.60M
27.95%
주식 보유 통계
마지막 업데이트: Thu, Jan 8
마지막 업데이트: Thu, Jan 8
주주
주주 유형
주주
주주
비율
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
기타
58.46%
주주
주주
비율
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
기타
58.46%
주주 유형
주주
비율
Investment Advisor
64.13%
Investment Advisor/Hedge Fund
37.62%
Hedge Fund
5.32%
Research Firm
2.06%
Pension Fund
1.58%
Sovereign Wealth Fund
1.12%
Bank and Trust
0.47%
Individual Investor
0.44%
Insurance Company
0.06%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
757
155.20M
112.77%
-15.97M
2025Q3
771
148.06M
107.58%
-20.94M
2025Q2
791
145.85M
106.01%
-21.49M
2025Q1
812
142.34M
103.61%
-25.15M
2024Q4
806
140.28M
102.80%
-22.73M
2024Q3
798
138.34M
101.41%
-20.68M
2024Q2
800
136.29M
99.93%
-16.34M
2024Q1
799
135.97M
99.77%
-20.56M
2023Q4
809
135.31M
99.86%
-23.17M
2023Q3
797
133.80M
98.82%
-17.47M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
T. Rowe Price Associates, Inc.
16.79M
12.2%
+2.36M
+16.34%
Sep 30, 2025
The Vanguard Group, Inc.
13.82M
10.04%
-144.87K
-1.04%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.97M
8.7%
+209.84K
+1.78%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
7.70M
5.59%
+181.83K
+2.42%
Sep 30, 2025
State Street Investment Management (US)
6.90M
5.02%
-437.33K
-5.96%
Sep 30, 2025
Neuberger Berman, LLC
5.73M
4.16%
+2.02M
+54.36%
Sep 30, 2025
Cooke & Bieler, L.P.
3.68M
2.67%
+381.29K
+11.56%
Sep 30, 2025
Sound Shore Management, Inc.
3.65M
2.65%
+363.33K
+11.05%
Sep 30, 2025
Thompson, Siegel & Walmsley LLC
3.63M
2.64%
+1.30M
+56.12%
Sep 30, 2025
DePrince, Race & Zollo, Inc.
3.54M
2.57%
-1.03M
-22.50%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Sound Equity Dividend Income ETF
3.3%
State Street SPDR S&P Pharmaceuticals ETF
2.44%
Invesco Pharmaceuticals ETF
2.34%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.54%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.35%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
1.32%
First Trust Health Care Alphadex Fund
1.22%
Invesco S&P MidCap 400 Pure Value ETF
1.19%
Invesco High Yield Equity Dividend Achievers ETF
1.11%
iShares U.S. Pharmaceuticals ETF
1.05%
더 보기
Sound Equity Dividend Income ETF
비율3.3%
State Street SPDR S&P Pharmaceuticals ETF
비율2.44%
Invesco Pharmaceuticals ETF
비율2.34%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
비율1.54%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율1.35%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
비율1.32%
First Trust Health Care Alphadex Fund
비율1.22%
Invesco S&P MidCap 400 Pure Value ETF
비율1.19%
Invesco High Yield Equity Dividend Achievers ETF
비율1.11%
iShares U.S. Pharmaceuticals ETF
비율1.05%
주식 배당금
지난 5년 동안 총
574.20M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Oct 29, 2025
PRGO.NB Final Cash Dividend of gross USD 0.29 paid on Dec 16, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 16, 2025
Nov 28, 2025
Jul 30, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Sep 16, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 16, 2025
Aug 29, 2025
Apr 30, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Jun 17, 2025 going ex on May 30, 2025
May 30, 2025
Jun 17, 2025
May 30, 2025
Feb 19, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Mar 25, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 25, 2025
Mar 07, 2025
Nov 01, 2024
PRGO.NB Final Cash Dividend of gross USD 0.276 paid on Dec 17, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 17, 2024
Nov 29, 2024
Aug 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Sep 17, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 17, 2024
Aug 30, 2024
May 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Jun 18, 2024 going ex on May 31, 2024
May 31, 2024
Jun 18, 2024
May 31, 2024
Feb 26, 2024
PRGO.NB Interim Cash Dividend of gross USD 1.1 paid on Mar 26, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 26, 2024
Mar 07, 2024
Nov 03, 2023
PRGO.NB Final Cash Dividend of gross USD 0.273 paid on Dec 19, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 19, 2023
Nov 30, 2023
Aug 02, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Sep 19, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 19, 2023
Aug 31, 2023
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Perrigo Company PLC의 상위 5대 주주는 누구인가요?
Perrigo Company PLC의 상위 5대 주주는 다음과 같습니다:
T. Rowe Price Associates, Inc.는 16.79M주의 주식을 보유하고 있으며, 전체 주식의 12.20%를 차지합니다.
The Vanguard Group, Inc.는 13.82M주의 주식을 보유하고 있으며, 전체 주식의 10.04%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 11.97M주의 주식을 보유하고 있으며, 전체 주식의 8.70%를 차지합니다.
Dimensional Fund Advisors, L.P.는 7.70M주의 주식을 보유하고 있으며, 전체 주식의 5.59%를 차지합니다.
State Street Investment Management (US)는 6.90M주의 주식을 보유하고 있으며, 전체 주식의 5.02%를 차지합니다.
T. Rowe Price Associates, Inc.는 16.79M주의 주식을 보유하고 있으며, 전체 주식의 12.20%를 차지합니다.
The Vanguard Group, Inc.는 13.82M주의 주식을 보유하고 있으며, 전체 주식의 10.04%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 11.97M주의 주식을 보유하고 있으며, 전체 주식의 8.70%를 차지합니다.
Dimensional Fund Advisors, L.P.는 7.70M주의 주식을 보유하고 있으며, 전체 주식의 5.59%를 차지합니다.
State Street Investment Management (US)는 6.90M주의 주식을 보유하고 있으며, 전체 주식의 5.02%를 차지합니다.
Perrigo Company PLC의 상위 3대 주주 유형은 무엇인가요?
Perrigo Company PLC의 주요 주주 유형 상위 3가지는
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.입니다.
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.입니다.
Perrigo Company PLC(PRGO)의 주식을 보유한 기관은 몇 개입니까?
2025Q4 기준으로, Perrigo Company PLC의 주식을 보유한 기관은 총 757곳이며, 이들이 보유한 주식의 총 가치는 약 155.20M로 전체 발행 주식의 112.77%를 차지합니다. 이는 2025Q3 대비 5.19% 증가한 수치입니다.
Perrigo Company PLC의 최대 수익원은 무엇인가요?
FY2025Q3 기준, Perrigo Company PLC의 Upper respiratory 부문이 가장 높은 매출을 기록했으며, 금액은 182.00M로 전체 매출의 17.44%를 차지했습니다.
